Indian Company Gets Manufacturing License For Russia’s COVID-19 Vaccine Sputnik V
MUMBAI, Jul 5 (NNN-PTI) – India’s Panacea Biotec, received manufacturing license, to produce Russia’s COVID-19 vaccine, Sputnik V, the company said yesterday. The license was granted by India’s drug regulator, pursuant to Panacea Biotec’s collaboration with Russian Direct Investment Fund, the sovereign wealth fund. Earlier in May, the batches of…
